Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Cancer Biology & Therapy|July 13, 2023
Developing and characterizing a two-layered safety switch for cell therapiesFilippo Rossignoli, Danielle Hoffman, Emaan Atif, et al.Trends in Molecular Medicine|January 26, 2022
NK cells in the brain: implications for brain tumor development and therapyAgisilaos Balatsoukas, Filippo Rossignoli, Khalid ShahCytotherapy|June 9, 2024
Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironmentIoulia Vogiatzi, Lucia Moreno Lama, Amelia Lehmann, et al.Frontiers in Immunology|August 20, 2024
Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized miceLongsha Liu, Thijs A van Schaik, Kok-Siong Chen, et al.Frontiers in Immunology|January 26, 2024
Establishment and immune phenotyping of patient-derived glioblastoma models in humanized miceLongsha Liu, Thijs A van Schaik, Kok-Siong Chen, et al.Stem Cells (Dayton, Ohio)|February 15, 2021
Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine stormNa Song, Hiroaki Wakimoto, Filippo Rossignoli, et al.Science Translational Medicine|January 4, 2023
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunityKok-Siong Chen, Clemens Reinshagen, Thijs A Van Schaik, et al.The Journal of Clinical Investigation|November 19, 2024
An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safetyKok-Siong Chen, Sarah Manoury-Battais, Nobuhiko Kanaya, et al.Cancer Biology & Therapy|May 24, 2005
Current advances in molecular imaging of gene and cell therapy for cancerKhalid ShahAdvanced Drug Delivery Reviews|July 12, 2011
Mesenchymal stem cells engineered for cancer therapyKhalid ShahPageof 16